AP NEWS

Non-Small Cell Lung Cancer - United States Market and Competitive Landscape (2018-2023) - ResearchAndMarkets.com

October 11, 2018

DUBLIN--(BUSINESS WIRE)--Oct 11, 2018--The “US Non-Small Cell Lung Cancer Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering

This report provides comprehensive insights into Non-Small Cell Lung Cancer pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares.

The study accurately estimates and forecast Non-Small Cell Lung Cancer market size and drug sales. This research also provides insights into Non-Small Cell Lung Cancer epidemiology and late stage pipeline.

The research is classified into following sections - Non-Small Cell Lung Cancer overview with definitions, symptoms, etiology, diagnosis, treatment options; Non-Small Cell Lung Cancer pipeline insights covering late stage clinical trials pipeline; Non-Small Cell Lung Cancer prevalence trends by countries; Non-Small Cell Lung Cancer market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Research Scope

Non-Small Cell Lung Cancer pipeline: Find out the drugs in clinical trials for Non-Small Cell Lung Cancer by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company Non-Small Cell Lung Cancer epidemiology: Find out the prevalence of Non-Small Cell Lung Cancer in US; prevalence forecast to 2023 Non-Small Cell Lung Cancer products: Identify key products marketed and prescribed for Non-Small Cell Lung Cancer by brand name, by molecule, by company, by branded / generic, in US Non-Small Cell Lung Cancer market size: Find out the market size for Non-Small Cell Lung Cancer drugs in US; Find out how the market advanced from 2014 Non-Small Cell Lung Cancer drug sales: Find out the sales of Non-Small Cell Lung Cancer drugs in US Non-Small Cell Lung Cancer drugs sales forecast: Sales forecast for Non-Small Cell Lung Cancer drugs to 2023 in US Non-Small Cell Lung Cancer market share analysis: Find out the market shares of Non-Small Cell Lung Cancer drugs and outlook in US

For more information about this report visit https://www.researchandmarkets.com/research/wtj9qp/nonsmall_cell?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181011005664/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Lung Cancer Drugs

KEYWORD: UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/11/2018 11:45 AM/DISC: 10/11/2018 11:45 AM

http://www.businesswire.com/news/home/20181011005664/en

AP RADIO
Update hourly